Characterization of Shewanella sp. Isolated from Cultured Loach Misgurnus anguillicaudatus

Shewanella infection of fish has become a significant problem in aquaculture. In September 2014, a disease was seen in cultured loach (Misgurnus anguillicaudatus) in Xuzhou, central China. A gram-negative bacillus was isolated from the diseased loaches and was tentatively named strain MS1, which was then identified as Shewanella sp. by physiological and biochemical characteristics analysis. The strain MS1 showed highest 16S rRNA sequence identities (98.93%, 98.87%) with the latest two species listed (Shewanella sp. MR7, Shewanella sp. MR4). The phylogenetic tree constructed on the basis of 16S rRNA gene sequences strongly indicated that the strain MS1 is most closely related to the new Shewanella strains MR7 and MR4. The isolate MS1 was confirmed as the pathogen of the infected loaches by experimental reinoculation. The strain was susceptible to most antimicrobial agents tested, but resistant to glycopeptides (vancomycin, teicoplanin) and lincosamide (lincomycin, clindamycin). This is the second report on Shewanella sp. isolated from the diseased loach

Longest Path Reroute to Optimize the Optical Multicast Routing in Sparse Splitting WDM Networks

Limited by the sparse light-splitting capability in WDM networks, some nodes need to reroute the optical packet to different destination nodes with the high cost of routing for reducing packet loss possibility. In the paper, the longest path reroute optimization algorithm is put forward to jointly optimize the multicast routing cost and wavelength channel assignment cost for sparse splitting WDM networks. Based on heuristic algorithms, the longest path reroute routing algorithm calls multiple longest paths in existing multicast tree to reroute the path passing from the nodes which are violating the light-splitting constraint to the nodes which are not violating light-splitting constraint with few wavelength channels and low rerouting cost. And a wavelength cost control factor is designed to select the reroute path with the lowest cost by comparing the multicast rerouting path cost increment with the equivalent wavelength channel required cost increment. By adjusting wavelength cost control factor, we can usually get the optimized multicast routing according to the actual network available wavelength conversion cost. Simulation results show that the proposed algorithm can get the low-cost multicast tree and reduce the required number of wavelength channels

Identification and isolation of Genotype-I Japanese Encephalitis virus from encephalitis patients

Historically, Japanese Encephalitis virus (JEV) genotype III (GIII) has been responsible for human diseases. In recent years, JEV genotype I (GI) has been isolated from mosquitoes collected in numerous countries, but has not been isolated from patients with encephalitis. In this study, we report recovery of JEV GI live virus and identification of JEV GI RNA from cerebrospinal fluid (CSF) of encephalitis patients in JE endemic areas of China. Whole-genome sequencing and molecular phylogenetic analysis of the JEV isolate from the CSF samples was performed. The isolate in this study is highly similar to other JEV GI strains which isolated from mosquitoes at both the nucleotide and deduced amino acid levels. Phylogenetic analysis based on the genomic sequence showed that the isolate belongs to JEV GI, which is consistent with the phylogenetic analysis based on the pre-membrane (PrM) and Glycoprotein genes. As a conclusion, this is the first time to isolate JEV GI strain from CSF samples of encephalitis patients, so continuous survey and evaluate the infectivity and pathogenecity of JEV GI strains are necessary, especially for the JEV GI strains from encephalitis patients. With respect to the latter, because all current JEV vaccines (live and inactivated are derived from JEV GIII strains, future studies should be aimed at investigating and monitoring cross-protection of the human JEV GI isolates against widely used JEV vaccines

The TRAPs From Microglial Vesicles Protect Against Listeria Infection in the CNS

Previous studies have demonstrated that T cells and microglia could fight against cerebral Listeria monocytogenes (Listeria); however, their synergistic anti-Listeria mechanisms remain unknown. Following Listeria infection in a culture system, we found that microglia, but not nerve cells, could release extracellular traps (ETs) which originated from microglial vesicles. Specific inhibitor analysis showed that extracellular DNA (eDNA), matrix metallopeptidases (MMP9 and MMP12), citrullinated histone H3, and peptidyl arginine deiminase 2 were the major components of microglial ETs (MiETs) and were also the components of vesicles. Systematic analysis indicated that Listeria-induced MiETs were cytosolic reactive oxygen species (ROS)- and NADPH oxidase (NOX)-dependent and involved ERK. MiETs were exhibited in Listeria-infected mouse brain and might protected against Listeria infection via bacterial killing in a mouse meningitis model, and MiETs existed in cerebrospinal fluid (CSF) from Listeria meningitis patients in vivo and in vitro. Additionally, interferon-γ could induce MiET formation in Listeria-infected microglia in vitro that was mediated by NOX, and there was a positive relationship between the elevated level of IFN-γ and eDNA and nucleosomes in the brain homogenates and CSF of Listeria meningitis model mice and in the CSF before treatment in clinical Listeria meningitis patients. Together, this is the first report of MiET formation, these findings pave the way for deeper exploration of the innate immune response to pathogens in CNS

Biochanin a Enhances the Defense Against Salmonella enterica Infection Through AMPK/ULK1/mTOR-Mediated Autophagy and Extracellular Traps and Reversing SPI-1-Dependent Macrophage (MΦ) M2 Polarization

A novel treatment regimen for bacterial infections is the pharmacological enhancement of the host's immune defenses. We demonstrated that biochanin A (BCA), an isoflavone constituent in some plants, could enhance both intra- and extracellular bactericidal activity of host cells. First, BCA could induce a complete autophagic response in nonphagocytic cells (HeLa) or macrophages (MΦ) via the AMPK/ULK1/mTOR pathway and Beclin-1-dependent manner, and BCA enhanced the killing of invading Salmonella by autophagy through reinforcing ubiquitinated adapter protein (LRSAM1, NDP52 and p62)-mediated recognition of intracellular bacteria and through the formation of autophagolysosomes. Second, we demonstrated that BCA could enhance the release of MΦ extracellular traps (METs) to remove extracellular Salmonella also via the AMPK/ULK1/mTOR pathway, not through reactive oxygen species (ROS) pathway. Furtherly, in a Salmonella-infected mouse model, BCA treatment increased intra- and extracellular bactericidal activity through the strengthening autophagy and MET production, respectively, in peritoneal MΦ, liver and spleen tissue. Additionally, our findings showed that BCA downregulated SPI-1 (Salmonella pathogenicity island 1) expression during Salmonella infection in vitro and in vivo to reverse the MΦ M2 polarization, which was different from the MΦ M1 phenotype caused by most of bacteria infection. Together, these findings suggest that BCA has an immunomodulatory effect on Salmonella-infected host cells and enhances their bactericidal activity in vitro and in vivo through autophagy, extracellular traps and regulation of MΦ polarization